Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Jones

Showing results (1501-1510 of 1,600) with videos related to

Pageof 160
Sort By:
Inorganic Chemistry|May 17, 2007
1,2,3-triazolate-bridged tetradecametallic transition metal clusters [M14(L)6O6(OMe)18X6] (M=FeIII, CrIII and VIII/IV) and related compounds: ground-state spins ranging from S=0 to S=25 and spin-enhanced magnetocaloric effectRachel Shaw, Rebecca H Laye, Leigh F Jones, et al.
European Journal of Cancer (Oxford, England : 1990)|April 16, 2013
A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumoursJeffrey R Infante, Kyriakos P Papadopoulos, Johanna C Bendell, et al.
European Journal of Human Genetics : EJHG|September 20, 2019
MNS1 variant associated with situs inversus and male infertilityJoseph S Leslie, Lettie E Rawlins, Barry A Chioza, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Angiopoietins 3 and 4: diverging gene counterparts in mice and humansD M Valenzuela, J A Griffiths, J Rojas, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid LeukemiaBogdan Popescu, Matthew F Jones, Madison Piao, et al.
Journal of Environmental Health|May 13, 2025
Church Jetted Baptismal Font Linked to Legionellosis Outbreak-Tennessee, 2023Christine M Thomas, Dilani Goonewardene, Julie Schuman, et al.
Investigational New Drugs|September 4, 2015
A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumorsSuzanne F Jones, Lillian L Siu, Johanna C Bendell, et al.
Harmful Algae|March 3, 2025
Nutrient limitation and seasonality associated with phytoplankton communities and cyanotoxin production in a large, hypereutrophic lakeGabriella M Lawson, Jakob L Young, Zachary T Aanderud, et al.
RSC Advances|May 6, 2022
Proline derived guanidine catalysts forge extensive H-bonded architectures: a solution and solid state studyZahraa S Al-Taie, Simon R Anetts, Jeppe Christensen, et al.
Epidemiology and Infection|February 13, 2018
Epidemiology and risk factors for hepatitis C virus infection in a high-prevalence populationM A Fill, L A Sizemore, M Rickles, et al.
Pageof 160

Showing results (1501-1510 of 1,600) with videos related to

Sort By:
Pageof 160
Inorganic Chemistry|May 17, 2007
1,2,3-triazolate-bridged tetradecametallic transition metal clusters [M14(L)6O6(OMe)18X6] (M=FeIII, CrIII and VIII/IV) and related compounds: ground-state spins ranging from S=0 to S=25 and spin-enhanced magnetocaloric effectRachel Shaw, Rebecca H Laye, Leigh F Jones, et al.
European Journal of Cancer (Oxford, England : 1990)|April 16, 2013
A phase 1b study of trametinib, an oral Mitogen-activated protein kinase kinase (MEK) inhibitor, in combination with gemcitabine in advanced solid tumoursJeffrey R Infante, Kyriakos P Papadopoulos, Johanna C Bendell, et al.
European Journal of Human Genetics : EJHG|September 20, 2019
MNS1 variant associated with situs inversus and male infertilityJoseph S Leslie, Lettie E Rawlins, Barry A Chioza, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 3, 1999
Angiopoietins 3 and 4: diverging gene counterparts in mice and humansD M Valenzuela, J A Griffiths, J Rojas, et al.
Biorxiv : the Preprint Server for Biology|July 15, 2025
Multi-selective RAS(ON) Inhibition Targets Oncogenic RAS Mutations and Overcomes RAS/MAPK-Mediated Resistance to FLT3 and BCL2 Inhibitors in Acute Myeloid LeukemiaBogdan Popescu, Matthew F Jones, Madison Piao, et al.
Journal of Environmental Health|May 13, 2025
Church Jetted Baptismal Font Linked to Legionellosis Outbreak-Tennessee, 2023Christine M Thomas, Dilani Goonewardene, Julie Schuman, et al.
Investigational New Drugs|September 4, 2015
A phase I study of VS-6063, a second-generation focal adhesion kinase inhibitor, in patients with advanced solid tumorsSuzanne F Jones, Lillian L Siu, Johanna C Bendell, et al.
Harmful Algae|March 3, 2025
Nutrient limitation and seasonality associated with phytoplankton communities and cyanotoxin production in a large, hypereutrophic lakeGabriella M Lawson, Jakob L Young, Zachary T Aanderud, et al.
RSC Advances|May 6, 2022
Proline derived guanidine catalysts forge extensive H-bonded architectures: a solution and solid state studyZahraa S Al-Taie, Simon R Anetts, Jeppe Christensen, et al.
Epidemiology and Infection|February 13, 2018
Epidemiology and risk factors for hepatitis C virus infection in a high-prevalence populationM A Fill, L A Sizemore, M Rickles, et al.
Pageof 160